Geron Announces FDA Acceptance of New Drug Application for Imetelstat for the Treatment of Lower Risk MDS

FOSTER CITY, Calif.--(BUSINESS WIRE) August 21, 2023 -- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has accepted the filing of...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news